Development of Psychotherapeutic Interventions for Parents Who Lost a Child

Share

Full Title

Development of Psychotherapeutic Interventions for Parents Who Lost a Child

Purpose

Many parents who have lost a child use counseling or other resources to help them cope with their grief and the emotional burden of their loss. The aim of this study is to compare two types of counseling programs for parents who have lost a child.

One of the types of counseling programs being assessed in this study is called Meaning-Centered Grief Therapy, an approach that aims to teach parents who have lost a child how to maintain or increase a sense of meaning and purpose in their lives, despite their loss. Participants will be encouraged to reflect on questions between sessions and, if possible, to write down their responses. Participants will also have the option of completing a larger project on their own based on the themes that will be discussed.

The other type of counseling program is supportive counseling, which aims to help parents cope with their loss by giving them a place to express their feelings and get support during the sessions.

For both types of counseling programs, parents participating in this study will receive counseling through Internet-based video conferencing. The researchers will see how successful it is to hold the sessions through video-conferencing and will refine the counseling programs based on the parents’ feedback. Each session will last about one hour, for a total of 16 sessions.

Who Can Join

This study will include parents who lost a child at least six months ago. Participants must reside in the states of New York or New Jersey or have the ability to complete sessions while complying with current telehealth regulations. Participants must be able to understand English well enough to complete the study assessments.

For more information about this study, please contact the research staff at 646-608-8330, or Dr. Wendy Lichtenthal at 646-608-8204.

Protocol

14-102

Investigator

Co-Investigators

ClinicalTrials.gov ID

NCT02153619